Home > Boards > US OTC > Medical - Drugs >

New York Health Care Inc (BBAL)

Add BBAL Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/20/2018 9:30:56 PM - Followers: 16 - Board type: Free - Posts Today: 0

New York Health Care, Inc. (BBAL) aka NYHC


Providing a full range of home health care services to the senior, disabled and rehabilitative patients in the greater New York Metropolitan Area, Long Island and Hudson Valley Areas.

Does your elderly parent or grandparent need home care, beyond what insurance covers? Perhaps you're not sure what kind of in-home care is needed. When in-home care services aren't fully covered by insurance, New York Health Care is your solution.

 Servicing NY Metropolitan Area Since 1983
 Licensed by NY State Dept of Health
 Accredited by the Joint Commission


Established in 1983, New York Health Care, Inc. was formed as a natural outgrowth of the increased demand for at-home health care services. We provide a full range of home health care services to the Senior, Disabled and Rehabilitative patient in the greater New York Metropolitan area, Long Island and Hudson Valley Areas.

  • The NYHC Nursing staff and our Para-Professional staff are certified or licensed in accordance with the NY State Dept. of Health Regulations.
  • At NYHC we are sensitive to the cultural needs of language requirements of our patients. Our Nurses and Home Health Aides are culturally diverse to meet the diversity catering to specialized dietary and religious restrictions.
  • NYHC services are available 24 hours / 7 days a week. With over 27 years of experience providing reliable homecare services to thousands of patients. We are there for you.

NEW YORK HEALTH CARE, INC. is licensed by the New York State Department of Health to operate as a Licensed Home Care Services Agency. NYHC makes every effort to anticipate our clients' needs. Our staff is carefully selected and trained to provide a wide range of services that make the patient feel like they are being treated by a family member.

  • Homecare services can be provided by the visit, (up to 4 hours) by the shift or Live-in (24 hours)
  • Our culturally diverse staff makes working with New York Health Care a breeze for the patient


  • Registered Professional Nurses
  • Licensed Practical Nurses
  • Home Health Aides
  • Homemaker / Housekeeper staff
  • Companionship services
  • Well Baby Nurses & Care Givers
  • Infusion Therapy Nurses
  • Pediatric Nurses
  • Geriatric Care
  • Management Services



  • New York Health Care, Inc.
    20 East Sunrise Hwy, Suite 201
    Valley Stream, NY 11581

  • PHONE:
New York Health Care Inc. has five locations in Brooklyn, Nassau, Hempstead, Bronx, Westchester. This allows us to service patients in neighboring counties.
  • New York City, Brooklyn, Queens & Staten Island
    6715 Bay Parkway
    Brooklyn NY 11204

  • Bronx
    384 East 149th Street, Suite 224
    Bronx, NY 10455

  • Westchester
    635 South Columbus Ave. 2nd Floor Suite 6,
    Mount Vernon NY 10550

  • Nassau County
    243 Fulton Ave ,Suite 222
    Hempstead NY 11550

  • Rockland County
    218 North Main Street
    Spring Valley, NY 10977

  • Orange County
    377 Fullerton Avenue
    Newburgh NY 12550

Company Officers:
CEO and Director: Murry Englard
CFO: Stewart W. Robinson
Director Information Services: Shalom Yurman


Manta Report:

New York Health Care, Inc Business Information

Location Type Headquarters
Annual Sales(Estimated) 44,399,303
Employees(Estimated) 1,462
At this location
SIC Code 2834, Pharmaceutical Preparations
NAICS Code 325412, Pharmaceutical Preparation Manufacturing
Products, Servicesand Brands Information not found
State of Incorporation New York
Years in Business 27


Enterologics Is Acquiring BioBalance Corp. and Probiotic Product from New York Health Care, Inc. 

Press Release Source: Enterologics, Inc. On Friday June 17, 2011, 5:00 am EDT 
SAINT PAUL, Minn.--(BUSINESS WIRE)-- Enterologics, Inc. (ELGO.OB) announced today that it is acquiring all the shares of The BioBalance Corporation and its subsidiary BioBalance LLC from New York Health Care, Inc. ("NYHC"). With this purchase Enterologics will acquire E. coli M17, or Probactrix®, a probiotic product being developed as a biologic drug under an active Investigational New Drug (IND) application for a pouchitis-related indication. Probiotics are live microorganisms (in most cases, bacteria) that are similar to or derived from beneficial microorganisms found in the human gut. They are also called "friendly bacteria" or "good bacteria." 

The acquisition also includes BioBalance's portfolio of intellectual property and regulatory filings. Terms of the acquisition include cash, stock and a 3-year promissory note. The sale is contingent upon receiving approval by NYHC's shareholders, with an expected closing date of no later than September 30, 2011. 

"By providing us with our first pipeline product, E. coli M17, the acquisition of BioBalance fulfills a key milestone in Enterologics' business strategy," said Bob Hoerr, Enterologics' president. "E. coli M17 coupled with the new formulation technology we are developing with Universal Stabilization Technologies provides us with a solid platform for our first probiotic biologic drug product. The fact that BioBalance was able to establish an active IND for E. coli M17 made it very attractive for acquisition. This further demonstrates the validity of our planned commercialization of high value probiotics as biologic drugs for specific gastrointestinal (GI) conditions." 

Dr. Hoerr stated that the formal development of E. coli M17 could begin quickly once the deal closes. He continued that the Company plans to reinitiate manufacturing with a partner as soon as feasible after closing. When cGMP production and the necessary financing are in place, the Company intends to begin clinical trials under the IND. 

"The sale of BioBalance will enable New York Health Care to concentrate on its core business," said Murry Englard, CEO of NYHC. "We are also very pleased that Enterologics is committed to developing E. coli M17 as a therapeutic agent. We made significant progress on this course until the economic downturn made obtaining the required financing impossible. As a focused GI therapeutic company, Enterologics is ideally suited to be successful." 

About Enterologics 

Enterologics, Inc. (OTCBB:ELGO.OB.ob - News) is a biotechnology company that is developing probiotics as biologic drugs for specific gastrointestinal disease indications. Probiotics are live microorganisms, in most cases, bacteria, that are similar to or derived from beneficial microorganisms that are found in the human gut (e.g. for more information see Introduction to Probiotics). They are also called "friendly bacteria" or "good bacteria." Enterologics intends to identify, in-license and develop unique probiotic strains for specific medical conditions, obtain regulatory approval and market these probiotics products as FDA-approved prescription drugs for specific label indications. More details are available at 

Forward-Looking Statements 

The U.S. Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. 

Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. 

The forward-looking statements in this release are based upon various assumptions. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that it will achieve or accomplish these expectations, beliefs or projections. Actual results could differ materially from those discussed in the forward-looking statements. Reference is made to our filings with the SEC.

Brief History of NYHC/BBAL:

BBAL Company Profile:

Share Structure:

33 Million Outstanding Shares

IR Contact Info
  • 1850 McDonald Avenue
  • Brooklyn, NY, 11223

BBAL Daily Chart


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#437   Only selling was the flip trade and I MGG2 02/20/18 09:30:55 PM
#436   $BBAL: There's your PENNY... MORE MORE MORE makinezmoney 02/20/18 01:18:17 PM
#435   $BBAL: On the run here.... now hitting $0.008 makinezmoney 02/20/18 01:15:01 PM
#434   Something up with this today> B/A is freaky!! NitWhit_needs_2_quit 10/04/11 11:40:55 AM
#433   Are we dead here? Seen a little NitWhit_needs_2_quit 09/07/11 11:43:00 AM
#432   Need news JetLifer 07/19/11 02:54:37 PM
#431   It's a long term thing that's why. JetLifer 07/14/11 12:24:46 PM
#430   Thanks. Not a lot of trading right NitWhit_needs_2_quit 07/14/11 12:06:53 PM
#429   Shareholders got to vote and the majority wants JetLifer 07/14/11 12:02:55 PM
#428   How did you find that out? NitWhit_needs_2_quit 07/14/11 11:27:30 AM
#427   I guess the acquisition is a success. Hopefully JetLifer 07/14/11 11:10:40 AM
#426   why is BBAL showing 130% gain bruderphillip 07/07/11 09:32:52 PM
#425 NitWhit_needs_2_quit 07/07/11 12:08:54 PM
#424   use your mind, buddy billowavetor 07/07/11 11:46:45 AM
#423   You people will learn that that MN#C and GrahamTrading 07/05/11 11:25:44 AM
#422   When is that supposed to take place. The R/S yaboy520 07/03/11 04:57:16 AM
#421   1 for 50000 R/S. This thing is done! NitWhit_needs_2_quit 06/30/11 09:45:29 AM
#420   yep, u right that monday was definately an stockmarketmadness 06/30/11 01:08:22 AM
#419   Ouch! :-) PipBoy 06/29/11 04:58:48 PM
#418   Just checked this out this thing is cheap. jermart 06/29/11 12:44:44 PM
#417   PROXYVOTE.COM You elected to receive shareholder communications and submit vo HDOGTX 06/29/11 11:00:03 AM
#416   Is this stock suspended? billowavetor 06/24/11 11:08:14 AM
#415   yeah it tanked not sure what the hell Sam Adams Beer 06/22/11 07:29:30 PM
#414   Wasnt this stock trading in the 5 cent yaboy520 06/22/11 06:27:42 PM
#413   What do you think will happen here? Sam Adams Beer 06/21/11 05:59:28 PM
#412   Huge short interest!!! I sold sum shares yesterday $King 06/21/11 10:47:45 AM
#411   BOUGHT SOME 16'S YESTERDAY HOPE TO MAKE MONEY Torqay 06/21/11 09:25:32 AM
#410   If everything is as the company says it stock-tipper 06/21/11 02:23:52 AM
#409   A nice bounce would be nice :) $King 06/20/11 10:31:31 PM
#408   If there's a buy out then everything should stock-tipper 06/20/11 10:22:09 PM
#407   35,020,000 shares of common stock, $0.0001 par value, Helter Skelter 06/20/11 08:58:54 PM
#406   Street Soldier ($ sign was playing havoc with Helter Skelter 06/20/11 08:52:41 PM
#405   Thanks for the DD...share structure 2mil volume on $King 06/20/11 08:14:10 PM
#404   Right. There are 3 companies involved in this...transaction. Helter Skelter 06/20/11 08:00:21 PM
#403   Hopefully we see a recovery in this one Sam Adams Beer 06/20/11 05:06:19 PM
#401   "IMO the PR was "phrased" just "so"....on MNYC 06/20/11 03:56:55 PM
#400   New York Health Care Inc (BBAL) is the DERBYBLOOD 06/20/11 03:53:56 PM
#399   Just a little info on what happens when layupdrill 06/20/11 02:50:45 PM
#398   ok I am not buying this anymore, I Torqay 06/20/11 02:26:37 PM
#397   They clearey stated they need shareholder approval and only money 06/20/11 02:01:15 PM
#396   This is an explicit contains that everybody understood, allezlOM 06/20/11 01:59:19 PM
#395   lol, let the misinformation begin, folks, layupdrill 06/20/11 01:57:48 PM
#394   Read the PR: MNYC 06/20/11 01:51:48 PM
#392   Come on sellers whre r u?? I need 0.008 Torqay 06/20/11 01:40:28 PM
#391   CLARIFICATION The Bio Balance transaction was not consummated until $King 06/20/11 01:40:20 PM
#389   "The sale of BioBalance will enable New York $King 06/20/11 01:35:27 PM
#387   Enterologics is buying BioBalance (BBAL), NYHC subsidiary $King 06/20/11 01:33:00 PM
#386   Apparently NOT "typical" MM B.S. I DERBYBLOOD 06/20/11 01:30:45 PM
#385   Typical MM BS NitWhit_needs_2_quit 06/20/11 12:55:23 PM
#384   Disappointing volume today. Didn't expect this at all MNYC 06/20/11 12:53:01 PM